Caitlin Miller
About Caitlin Miller
Caitlin Miller is a Senior Scientist at Arpeggio Bio, specializing in RNA sequencing and biochemical assays for drug development. She holds a PhD in Pathology and Laboratory Medicine from Boston University and has extensive experience in next-generation sequencing technologies.
Work at Arpeggio Bio
Caitlin Miller has been employed at Arpeggio Bio as a Senior Scientist since 2021. In this role, she focuses on the development of novel RNA sequencing platforms tailored for oncology drug development. Her responsibilities include the design and execution of biochemical assays aimed at measuring enzymatic activity for drug screening. This work contributes to advancing the field of oncology by enhancing drug development processes.
Education and Expertise
Caitlin Miller earned her Doctor of Philosophy (PhD) in Pathology and Laboratory Medicine from Boston University School of Medicine, completing her studies from 2011 to 2017. Prior to this, she obtained a Bachelor of Science (BS) in Biochemistry from Gonzaga University, where she studied from 2007 to 2011. Her educational background provides a strong foundation for her expertise in RNA quality control and library preparation for next-generation sequencing technologies.
Background
Before joining Arpeggio Bio, Caitlin Miller worked as a Postdoctoral Fellow at the University of Colorado Denver from 2017 to 2021. During her four years in this position, she gained significant experience in cell culture treatment and the generation of samples for next-generation sequencing technologies, including nascent RNA sequencing. This experience has contributed to her current role in the biotechnology sector.
Achievements
Caitlin Miller has demonstrated proficiency in various technical skills relevant to her field. She specializes in viability screening of drugs in cell culture using Cell Titer Glo, which is essential for evaluating drug effectiveness. Her work in developing RNA sequencing platforms and executing biochemical assays has positioned her as a knowledgeable professional in oncology drug development.